Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Riedel, RF; Crawford, J; Dunphy, F; Herndon, JE; Garst, J; Kelley, MJ

Published Date

  • December 2006

Published In

Volume / Issue

  • 54 / 3

Start / End Page

  • 431 - 432

PubMed ID

  • 17005294

Pubmed Central ID

  • 17005294

International Standard Serial Number (ISSN)

  • 0169-5002

Digital Object Identifier (DOI)

  • 10.1016/j.lungcan.2006.08.008

Language

  • eng

Conference Location

  • Ireland